Efficacy and Safety of Iclepertin (BI 425809) in Patients With Schizophrenia

5 Likes

This is exciting.

1 Like

I was in the process of enrolling in the phase 3 trial for iclepertin back in September but me and the study coordinator lost touch. This reminded me to reach back out. She got right back to me and I’m still eligible to participate. Thanks @everhopeful!!

1 Like